SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001651308-24-000088
Filing Date
2024-07-24
Accepted
2024-07-24 17:23:32
Documents
3
Period of Report
2024-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1721856205.html 3  
1 FORM 3 wk-form3_1721856205.xml 3 1740
2 EX-24 poa-rosenbergx20240718.htm EX-24 4857
3 poa-rosenbergx20240718001.jpg GRAPHIC 250821
  Complete submission text file 0001651308-24-000088.txt   353657
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 55 CAMBRIDGE PARKWAY SUITE 700W CAMBRIDGE MA 02142
Business Address
Rosenberg Aaron (Reporting) CIK: 0002031182 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37686 | Film No.: 241139081